Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1C | Q13936 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.41 |
| ▸ | HTR2A | P28223 | 4/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.39 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.39 |
| ▸ | GRM5 | P41594 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29447128 | 1.00 | CACNA1C (1.00) | CACNA1CMAPTLMNAATML3MBTL1 | |
| Hydrochloric Acid SCHEMBL7028351 | 0.99 | CACNA1C (0.98) | CACNA1CMAPTLMNAATML3MBTL1 | |
| Hydrochloric Acid SCHEMBL7027262 | 0.89 | CACNA1C (0.80) | CACNA1CMAPTLMNAATML3MBTL1 | |
| SCHEMBL7026458 | 0.89 | CACNA1C (0.80) | CACNA1CMAPTLMNAATML3MBTL1 | |
| Hydrochloric Acid SCHEMBL7030534 | 0.88 | CACNA1C (0.78) | CACNA1CMAPTLMNAATML3MBTL1 | |
| SCHEMBL12389509 | 0.86 | CACNA1C (0.76) | CACNA1CMAPTLMNAATML3MBTL1 | |
| Hydrochloric Acid SCHEMBL7022421 | 0.85 | CACNA1C (0.73) | CACNA1CMAPTLMNAATML3MBTL1 | |
| SCHEMBL7027453 | 0.83 | CACNA1C (0.71) | CACNA1CMAPTSLC6A4HTR2AKCNH2 | |
| Hydrochloric Acid SCHEMBL7028292 | 0.82 | CACNA1C (0.70) | CACNA1CMAPTSLC6A4HTR2AGAA | |
| Hydrochloric Acid SCHEMBL7024465 | 0.81 | CACNA1C (0.68) | CACNA1CMAPTLMNAATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3021856-B1 | COMPOSITION FOR INDUCING ORGAN ARREST AND PROTECTION, PRESERVATION AND REDUCTION OF TISSUE INJURY | HIBERNATION THERAPEUTICS A KF LLC (US) | 2020-10-07 | — | — | EP | disclosed |
| US-10786525-B2 | Method for treating haemorrhage, shock and brain injury | HIBERNATION THERAPEUTICS A KF LLC (US) | 2020-09-29 | — | — | US | disclosed |
| US-10251905-B2 | Tissue maintenance | HIBERNATION THERAPEUTICS, A KF LLC (US) | 2019-04-09 | — | — | US | disclosed |
| EP-2079301-B1 | IMPROVED TISSUE MAINTENANCE | HIBERNATION THERAPEUTICS A KF LLC (US) | 2017-03-15 | — | — | EP | disclosed |
| US-20160374331-A1 | ORGAN PRECONDITIONING, ARREST, PROTECTION, PRESERVATION AND RECOVERY | HIBERNATION THERAPEUTICS, A KF LLC (US) | 2016-12-29 | — | — | US | disclosed |
| US-20160271161-A1 | METHOD FOR TREATING HAEMORRHAGE, SHOCK AND BRAIN INJURY | HTS THERAPEUTICS PTY LTD (AU) | 2016-09-22 | — | — | US | disclosed |
| US-20160166598-A1 | A METHOD FOR TREATING INFECTION, SEPSIS AND INJURY | HTS THERAPEUTICS PTY LTD (AU) | 2016-06-16 | — | — | US | disclosed |
| US-20160158280-A1 | A METHOD FOR ORGAN ARREST, PROTECTION AND PRESERVATION AND REDUCING TISSUE INJURY | HTS THERAPEUTICS PTY LTD (AU) | 2016-06-09 | — | — | US | disclosed |
| EP-3021855-A1 | A METHOD FOR TREATING HAEMORRHAGE, SHOCK AND BRAIN INJURY | Hibernation Therapeutics, a KF LLC (US) | 2016-05-25 | — | — | EP | disclosed |
| EP-3021856-A1 | A METHOD FOR ORGAN ARREST, PROTECTION AND PRESERVATION AND REDUCING TISSUE INJURY | Hibernation Therapeutics, a KF LLC (US) | 2016-05-25 | — | — | EP | disclosed |
| EP-1475103-A1 | REMEDIES FOR CHRONIC KIDNEY DISEASES | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2004-11-10 | — | — | EP | disclosed |
| EP-1475102-A1 | REMEDY FOR HYPERTENSION | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2004-11-10 | — | — | EP | disclosed |
| WO-2004056181-A1 | ORGAN PRECONDITIONING, ARREST, PROTECTION, PRESERVATION AND RECOVERY (2) | GLOBAL CARDIAC SOLUTIONS PTY LTD (AU) | 2004-07-08 | — | — | WO | disclosed |
| WO-2004056180-A1 | ORGAN PRECONDITIONING, ARREST, PROTECTION, PRESERVATION AND RECOVERY (1) | GLOBAL CARDIAC SOLUTIONS PTY LTD (AU) | 2004-07-08 | — | — | WO | disclosed |
| US-20040005576-A1 | Proteins and nucleic acids encoding same | CURAGEN CORPORATION | 2004-01-08 | — | — | US | disclosed |
| EP-1366162-A2 | PUTATIVE PROTEINS AND NUCLEIC ACIDS ENCODING SAME | Curagen Corporation (US) | 2003-12-03 | — | — | EP | disclosed |
| EP-1031556-B1 | 2-PHENOXYANILINE DERIVATIVES | TAISHO PHARMACEUTICAL CO LTD (JP) | 2003-01-22 | — | — | EP | disclosed |
| WO-2002046409-A2 | PROTEINS AND NUCLEIC ACIDS ENCODING SAME | CURAGEN CORPORATION (US) | 2002-06-13 | — | — | WO | disclosed |
| US-6162832-A | 2-Phenoxyaniline derivatives | TAISHO PHARMACEUTICAL CO., INC. (JP) | 2000-12-19 | — | — | US | disclosed |
| EP-1031556-A1 | 2-PHENOXYANILINE DERIVATIVES | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2000-08-30 | — | — | EP | disclosed |